Optibiotix Health Share Discussion Threads

[scotty1] 19/1/2017 10:45

Optibiotix - another cracking hire offsets Zak Mir buy tip
PUBLISHED: 19 Jan 2017 @ 07:05

The good news is that Optibiotix (LSE:OPTI) has hired another heavy hitter. Christina Wood has been appointed as Sales and Marketing Director. Christina will join the OptiBiotix Board subject to completion of the normal regulatory due diligence

The CV looks impressive. Ms Wood has more than 20 years’ sales experience within the food, nutrition, and nutraceuticals industry. Optibiotix reports:

As the owner and CEO of Confoco, a supplier of high quality food ingredients worldwide, Christina grew the business from £1m to £10m sales by obtaining strategic supplier status with multiple global corporates including Nestlé, Danone, and Heinz. During this time, she developed a network of agents and distributors across key international markets. Christina sold her company to Diana Naturals in 2013 which was subsequently acquired by Symrise AG for US$1.75 billion in 2014. She joined John Morley, a leading food industry supplier, in late 2014 where as Director of Sales and Marketing, she was responsible for key consumer accounts including Sainsbury’s, Waitrose, M&S and Tesco.

Ends.

Jolly good. We expect more news in the coming weeks on the Tata deal and also on other commercial agreements. Now for the less good news. Chartist Zak Mir has tipped the shares as a buy with a 105p short term price target. Like the broken clock we think that Mr Mir is on this occasion correct.

The shares – now 70p-72p – are a buy at up to 80p with a target to sell of 100p+ likely to be achieved pretty soon.

[someuwin] 19/1/2017 10:34

The tide has certainly turned here.

Could see 75p+ today.

[judijudi] 19/1/2017 10:26

Can get 10,000 at 73p with my broker
Although stock is tight

[rafboy] 19/1/2017 10:12

Yes, I had trouble buying 4k shares earlier and had to pay 73p!

[someuwin] 19/1/2017 10:10

Can't get an online buy quote for £1k

[bernieboy] 19/1/2017 08:45

Blue soon methinks....

[neftanikoff] 19/1/2017 08:24

i make it's currently 69.65 to sell and 71.9 to buy
edit, now 70.65 to sell

[parob] 19/1/2017 08:11

Not sure why the bid has dropped. I can sell 25K online for 71.4p.Is there another large buy order being worked again?

[parob] 19/1/2017 07:22

Barchart is now signalling an overall average of 56% buy - up from 48% buy after Friday's rise:



The chart is looking good and from the posts above it sounds like Zak agrees!

[someuwin] 18/1/2017 22:47

And after rising 370% (500%+ at one stage) FITB ended the day suspended 'pending an announcement'.

Good news or bad? Was the whole rise a pump to get a placing away?

Will be interesting to watch tomorrow.

[neftanikoff] 18/1/2017 22:35

Thanks, nicktoten, and the other share of course went up 300%, not 3000% and i can't even say drink was an excuse for those 2 errors.

[nicktopten] 18/1/2017 22:19

Neft, its Tata who Opti are dealing with.

[onedayrodders] 18/1/2017 20:10

Big news coming here...my source in a red and white suit told me 25th December is the date.

[elrico] 18/1/2017 20:09

Jumps like FITBUG tend to leave many PI out of pocket and those riding from the low would have been praying they get something back after being suckered into previous rallies only to see a rapid retrace. It's in a very crowded space and MAY NEED money ASAP.

[siennadelekat21] 18/1/2017 19:58

I think it jumped over 500% at one point Neft (while I looked on jealously)... and if you had been quick with the trigger finger people could've actually jumped on that rocket first thing as the MMs only opened up a little above yesterday's close. That would certainly be Awesome if we saw a rise like that from OPTI on a great bit of news.... but I don't think we'll see that sort of jump from our current level (FItbug were pretty much at an all time low and so had a long way to go). CheersSienna

[judijudi] 18/1/2017 19:34

3,000%
Don't think so neft
Ended up Approx 370%

[neftanikoff] 18/1/2017 19:26

o/t did you see that rise in FITBUG (FITB) today, over 3,000%, after an order win with,i think, TARA, is that the same as opti might be in with, or am i completely wrong ?

[someuwin] 18/1/2017 19:09

"Optibiotix: Broadening formation points towards 90p

By Zak Mir 18 January 2017

Optibiotix (LON:OPTI) has been one of those rare beasts: a reliable small cap company prospect. Here the shares have gone up, and largely stayed up.

As luck would have it, today I bumped into the CEO of Optibiotix, Stephen O’Hara. The company is one I have followed from the word go, and its continued progress is most welcome. The particular areas this company is tackling are among the most difficult to address or indeed treat. I am of course referring to obesity, high cholesterol, diabetes and skin care.

What can be seen on the daily chart in the journey from the autumn of 2015 is that we were treated to a break above the 40p region, with there being a brief near vertical move through 100p for November. Essentially, what can be deduced about the price action since then is that we have essentially been in consolidation mode within a broad triangle with its support line projection running towards 60p.

This implies that while above the floor of this formation on a weekly close basis, we are very much expecting the shares to deliver a decent new leg to the upside, and not just a temporary blip. Evidence for this would come from a weekly close above the 200 day moving average at 73.5p. As long as you wait on a clearance of the 200 day line, the upside here at Optibiotix should be 105p plus at the top of the triangle formation."

[elrico] 18/1/2017 19:04

I can be :-)

[elrico] 18/1/2017 18:55

Life sciences group OptiBiotix Health plc (LON:OPTI) is bringing on board an experienced sales and marketing director to help create new revenue streams for OptiBiotix’s pipeline of products.

Christina Wood will join the team in due course subject to the completion of the normal regulatory due diligence, Opti said.

She has been brought in to help take OptiBiotix’s products, including its patented SlimBiome weight loss products, into overseas markets.

Wood has more than 20 years’ sales experience in the food, nutrition and nutraceuticals industry and has struck deals with likes of Nestlé, Danone and Heinz in the past in her role as chief executive and owner of ingredients supplier Confoco.

Most recently, she was the director of sales and marketing at UK food supplier John Morley where she was responsible for key accounts including Tesco PLC (LON:TSCO) and J Sainsbury plc (LON:SBRY).

“Christina's experience of building sales in her own business by developing relationships with food ingredient manufacturers and major retailers brings new elements of operational, commercial and industry expertise to OptiBiotix,” said chief executive Stephen O’Hara in this morning’s statement.

Speaking exclusively to Proactive, he added: “You can see we’re transitioning now from a company that was very much focused on developing products to a company that is now commercialising their products.”

Shares were up 5.5%, or 3.8p, to 72.3p.

[judijudi] 18/1/2017 18:25

Funny :)
Have you never read any of Diamonds predictions before?
I guess not!!